S2M logo

S2Medical AB (publ)OM:S2M Stock Report

Market Cap SEK 12.0m
Share Price
SEK 0.014
My Fair Value
SEK 0.52
97.2% undervalued intrinsic discount
1Y-65.7%
7D10.8%
Portfolio Value
View

S2Medical AB (publ)

OM:S2M Stock Report

Market Cap: SEK 12.0m

S2M Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

S2Medical AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for S2Medical
Historical stock prices
Current Share PriceSEK 0.014
52 Week HighSEK 0.06
52 Week LowSEK 0.0055
Beta2.14
1 Month Change-1.37%
3 Month Change-33.02%
1 Year Change-65.71%
3 Year Change-98.86%
5 Year Change-99.83%
Change since IPO-99.92%

Recent News & Updates

Recent updates

Shareholder Returns

S2MSE Medical EquipmentSE Market
7D10.8%0.03%0.4%
1Y-65.7%-15.2%0.1%

Return vs Industry: S2M underperformed the Swedish Medical Equipment industry which returned -15.2% over the past year.

Return vs Market: S2M underperformed the Swedish Market which returned 0.1% over the past year.

Price Volatility

Is S2M's price volatile compared to industry and market?
S2M volatility
S2M Average Weekly Movement17.4%
Medical Equipment Industry Average Movement7.6%
Market Average Movement5.8%
10% most volatile stocks in SE Market13.2%
10% least volatile stocks in SE Market3.1%

Stable Share Price: S2M's share price has been volatile over the past 3 months compared to the Swedish market.

Volatility Over Time: S2M's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of Swedish stocks.

About the Company

FoundedEmployeesCEOWebsite
20137Petter Sivlerwww.s2m.se

S2Medical AB (publ) develops, produces, and sells wound healing products for burns and chronic wounds in Sweden. It offers Epiprotect 2117, a synthetic allograft/xenograft substitute; Epiprotect Ulcer, a wound dressing consisting of a thin film of biosynthetic cellulose polymer intended to be used as a protective barrier for superficial wounds and deep wounds that have breached the dermis, as well as used as a temporary coverage for deep extensive wounds before transplantation or other surgical intervention. The company also provides washable, durable, waterproof, and self-adhesive bandages under the INSTABIND brand name, as well as NO SMELL, a perfume-free odour remover; BIOPAD, an ivory-white soft sponge; and INSTAQRETT, a sterile mechanical debridement tool for, among other things, multi-resistant Staphylococci.

S2Medical AB (publ) Fundamentals Summary

How do S2Medical's earnings and revenue compare to its market cap?
S2M fundamental statistics
Market capSEK 11.99m
Earnings (TTM)SEK 4.81m
Revenue (TTM)SEK 14.68m
2.5x
P/E Ratio
0.8x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
S2M income statement (TTM)
RevenueSEK 14.68m
Cost of RevenueSEK 765.20k
Gross ProfitSEK 13.91m
Other ExpensesSEK 9.10m
EarningsSEK 4.81m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.0057
Gross Margin94.79%
Net Profit Margin32.78%
Debt/Equity Ratio0%

How did S2M perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/08/15 19:19
End of Day Share Price 2025/08/15 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

S2Medical AB (publ) is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.